The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Ultrasmall platinum nanoparticles enable deep tumor penetration and synergistic therapeutic abilities through free radical species-assisted catalysis to combat cancer multidrug resistance
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kankala et al successfully prepared a versatile drug delivery platform based on nanocarriers by coating the ultrasmall Pt nanoparticles by a composite layer of chitosan over the Zn-doped MSNs to combat MDR in cancer efficaciously.37”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [37]
Citations
Cites
Li, H.-J., Du, J.-Z., Liu, J., Du, X.-J., Shen, S., Zhu, Y.-H., Wang, X., Ye, X., Nie, S., & Wang, J. (2016) · ACS Nano · doi:10.1021/acsnano.6b02326 · Cited by 537
Nanoformulations for combination or cascade anticancer therapy
Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.003 · Cited by 178
Research works printed but not linked: 44
- He, 2011, A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance, Biomaterials, 32, 7711, 10.1016/j.biomaterials.2011.06.066 · DOI
- Kankala, 2017, Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics, J. Mater. Chem. B, 5, 1507, 10.1039/C6TB03146C · DOI
- Bharali, 2009, Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers, Int. J. Nanomed, 4, 1
- Shen, 2015, Topotecan-loaded mesoporous silica nanoparticles for reversing multi-drug resistance by synergetic chemoradiotherapy, Chem. Asian J., 10, 344, 10.1002/asia.201403117 · DOI
- Kankala, 2019, Metal species-encapsulated mesoporous silica nanoparticles: current advancements and latest breakthroughs, Adv. Funct. Mater., 10.1002/adfm.201902652 · DOI
- Kankala, 2018, Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds, Int. J. Nanomed., 13, 4227, 10.2147/IJN.S166124 · DOI
- Zhan, 2015, Thermo/redox/pH-triple sensitive poly(N-isopropylacrylamide-co-acrylic acid) nanogels for anticancer drug delivery, J. Mater. Chem. B, 3, 4221, 10.1039/C5TB00468C · DOI
- Elumalai, 2015, Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers, Nanomedicine, 11, 969, 10.1016/j.nano.2015.01.005 · DOI
- Chen, 2019, A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer, Nanoscale, 11, 3814, 10.1039/C8NR06218H · DOI
- Wang, 2015, Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance, Chem. Commun., 51, 11587, 10.1039/C5CC04376J · DOI
- Ediriwickrema, 2014, Multi-layered nanoparticles for combination gene and drug delivery to tumors, Biomaterials, 35, 9343, 10.1016/j.biomaterials.2014.07.043 · DOI
- Ma, 2013, Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review, Nano Today, 8, 313, 10.1016/j.nantod.2013.04.006 · DOI
- Lin, 2014, Cationic micellar nanoparticles for DNA and doxorubicin co-delivery, Mater. Sci. Eng. C, 44, 430, 10.1016/j.msec.2014.07.049 · DOI
- Jabr-Milane, 2008, Multi-functional nanocarriers to overcome tumor drug resistance, Cancer Treat. Rev., 34, 592, 10.1016/j.ctrv.2008.04.003 · DOI
- Chen, 2013, Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation, Int. J. Nanomed., 8, 1463
- Gao, 2011, Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles, ACS Nano, 5, 9788, 10.1021/nn2033105 · DOI
- Zhang, 2015, DNA-hybrid-gated photothermal mesoporous silica nanoparticles for NIR-responsive and aptamer-targeted drug delivery, ACS Appl. Mater. Interfaces, 7, 20696, 10.1021/acsami.5b05522 · DOI
- Yang, 2016, Reversing cancer multidrug resistance in xenograft models via orchestrating multiple actions of functional mesoporous silica nanoparticles, ACS Appl. Mater. Interfaces
- Huang, 2011, Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein–mediated drug resistance, Mol. Cancer Ther., 10, 761, 10.1158/1535-7163.MCT-10-0884 · DOI
- Jia, 2015, Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance, Int. J. Pharm., 489, 318, 10.1016/j.ijpharm.2015.05.010 · DOI
- Liang, 2018, Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy, J. Colloid Interface Sci., 525, 1, 10.1016/j.jcis.2018.04.058 · DOI
- Cheng, 2017, TPGS-functionalized polydopamine-modified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance, Small, 13, 1700623, 10.1002/smll.201700623 · DOI
- Tarn, 2013, Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility, Acc. Chem. Res., 46, 792, 10.1021/ar3000986 · DOI
- Wu, 2013, Synthesis of mesoporous silica nanoparticles, Chem. Soc. Rev., 42, 3862, 10.1039/c3cs35405a · DOI
- Argyo, 2014, Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery, Chem. Mater., 26, 435, 10.1021/cm402592t · DOI
- Travaglini, 2019, Highly degradable imine-doped mesoporous silica particles, Mater. Chem. Front., 3, 111, 10.1039/C8QM00438B · DOI
- Lee, 2009, Mesoporous materials for encapsulating enzymes, Nano Today, 4, 165, 10.1016/j.nantod.2009.02.001 · DOI
- Zeng, 2017, A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond, Adv. Funct. Mater., 27, 1605985, 10.1002/adfm.201605985 · DOI
- Cheng, 2017, A Multifunctional nanoplatform against multidrug resistant cancer: merging the best of targeted chemo/gene/photothermal therapy, Adv. Funct. Mater., 27, 1704135, 10.1002/adfm.201704135 · DOI
- Lee, 2010, Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics, Angew. Chem. Int. Ed., 49, 8214, 10.1002/anie.201002639 · DOI
- Kankala, 2015, Killing cancer cells by delivering a nanoreactor for inhibition of catalase and catalytically enhancing intracellular levels of ROS, RSC Adv., 5, 86072, 10.1039/C5RA16023E · DOI
- Kankala, 2017, Overcoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive, ROS-generating nanoreactors, ACS Biomater. Sci. Eng., 3, 2431, 10.1021/acsbiomaterials.7b00569 · DOI
- Liu, 2019, Rerouting engineered metal-dependent shapes of mesoporous silica nanocontainers to biodegradable Janus-type (sphero-ellipsoid) nanoreactors for chemodynamic therapy, Chem. Eng. J., 370, 1188, 10.1016/j.cej.2019.03.272 · DOI
- Ernsting, 2013, Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles, J. Control. Release, 172, 782, 10.1016/j.jconrel.2013.09.013 · DOI
- Cun, 2018, A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration, Nanoscale, 10, 9935, 10.1039/C8NR00640G · DOI
- Zhang, 2018, Rational design of nanoparticles with deep tumor penetration for effective treatment of tumor metastasis, Adv. Funct. Mater., 28, 1801840, 10.1002/adfm.201801840 · DOI
- Lee, 2008, Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug, Adv. Funct. Mater., 18, 3283, 10.1002/adfm.200800521 · DOI
- Singh, 2015, Designing casein-coated iron oxide nanostructures (CCIONPs) as superparamagnetic core-shell carriers for magnetic drug targeting, Prog. Biomater., 4, 39, 10.1007/s40204-014-0035-6 · DOI
- Yang, 2008, Preparation of polymer-coated mesoporous silica nanoparticles used for cellular imaging by a “graft-from” method, J. Mater. Chem., 18, 5731, 10.1039/b811573g · DOI
- Keng, 2009, Colloidal polymerization of polymer-coated ferromagnetic nanoparticles into cobalt oxide nanowires, ACS Nano, 3, 3143, 10.1021/nn900483w · DOI
- Zak, 2011, Synthesis and characterization of a narrow size distribution of zinc oxide nanoparticles, Int. J. Nanomed., 6, 1399
- Löffler, 2001, Synthesis and characterization of catalyst layers for direct methanol fuel cell applications, Phys. Chem. Chem. Phys., 3, 333, 10.1039/b005055p · DOI
- Kumar, 2013, Synthesis, characterization and optical properties of zinc oxide nanoparticles, Int. Nano Lett., 3, 30, 10.1186/2228-5326-3-30 · DOI
- Tovt, 2019, Ultimate dispersion of metallic and ionic platinum on ceria, J. Mater. Chem. A, 7, 13019, 10.1039/C9TA00823C · DOI
Cited by
Sorted by citations
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Metadata
- Authors
- Kankala, R. K., Liu, C.-G., Yang, D.-Y., Wang, S.-B., & Chen, A.-Z.
- Venue
- Chemical Engineering Journal
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 383
- Pages
- 123138
- ISSN
- 1385-8947
- Cited by
- 157
- References
- 2
- Language
- en
- Funders
- Fundamental Research Funds for the Central Universities
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review